Teva Pharmaceutical Industries on Thursday announced that the U.S. Court of Appeals for the Federal Circuit upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb's entecavir compound claim of U.S. Patent No. 5,206,244 invalid.
A study published Wednesday on JAMA's website found that diabetes patients taking metformin had a higher risk of all-cause death when insulin was added to their treatment as compared to when sulfonylureas were added to treatment.
In preparation for the grand re-opening of the Rite Aid located at 300 North Canon Dr. in Beverly Hills, the company on Thursday announced it will kick off the celebration by hosting 21 days of special events for customers.
Meals to Heal on Thursday announced that it is working with Walgreens to provide Meals to Heal services to cancer patients and others with chronic conditions in accessing customized nutritional meals and nutrition support services.
Valeant Pharmaceuticals International announced that its subsidiary, Valeant Pharmaceuticals North America, received approval from the Food and Drug Administration for its new drug application for Jublia (efinaconazole 10% topical solution). The drug is the first topical triazole approved for the treatment of onychomycosis of the toenails, the company said.